Scarica l'app Stockscreener
33.76
8.12%
-2.985
Dopo l'orario di chiusura:
33.87
0.115
+0.34%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$36.74
Aprire:
$36.44
Volume 24 ore:
3.88M
Relative Volume:
2.51
Capitalizzazione di mercato:
$1.74B
Reddito:
$190.41M
Utile/perdita netta:
$20.48M
Rapporto P/E:
151.50
EPS:
0.2228
Flusso di cassa netto:
$46.66M
1 W Prestazione:
-14.93%
1M Prestazione:
-9.36%
6M Prestazione:
-37.05%
1 anno Prestazione:
-31.15%
Intervallo 1D:
$32.88
$36.65
Intervallo di 1 settimana:
$32.88
$41.10
Portata 52W:
$32.63
$90.32
Soleno Therapeutics Inc Stock (SLNO) Company Profile
Nome
Soleno Therapeutics Inc
Settore
Industria
Telefono
650-213-8444
Indirizzo
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA
Compare SLNO vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SLNO
Soleno Therapeutics Inc
|
33.76 | 1.74B | 190.41M | 20.48M | 46.66M | 0.2228 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 119.23B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.84B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.35B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 41.57B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-18 | Iniziato | Wolfe Research | Outperform |
| 2025-10-07 | Iniziato | Goldman | Buy |
| 2025-08-20 | Iniziato | Wells Fargo | Overweight |
| 2025-06-23 | Iniziato | TD Cowen | Buy |
| 2025-03-05 | Ripresa | Stifel | Buy |
| 2024-12-02 | Reiterato | Robert W. Baird | Outperform |
| 2024-12-02 | Reiterato | Stifel | Buy |
| 2024-09-03 | Iniziato | H.C. Wainwright | Buy |
| 2024-05-10 | Iniziato | Robert W. Baird | Outperform |
| 2024-02-05 | Iniziato | Piper Sandler | Overweight |
| 2024-01-23 | Iniziato | Stifel | Buy |
| 2023-11-21 | Ripresa | Guggenheim | Buy |
| 2020-09-29 | Iniziato | Guggenheim | Buy |
| 2020-01-10 | Iniziato | Craig Hallum | Buy |
| 2019-12-23 | Iniziato | Oppenheimer | Outperform |
| 2018-02-13 | Reiterato | Maxim Group | Buy |
Mostra tutto
Soleno Therapeutics Inc Borsa (SLNO) Ultime notizie
Soleno Therapeutics, Inc. (SLNO) Securities Fraud Class Action Lawsuit Filed; May 5, 2026, Lead Plaintiff Deadline - PR Newswire
Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Camping World Holdings, Inc. (NYSE: CWH); EOS Energy Enterprise, Inc. (NASDAQ: EOSE); and Soleno Therapeutics, Inc. (NASDAQ: SLNO): Grabar Law Office Investigates Claims on - lincolnjournal.com
Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Camping World Holdings, Inc. (NYSE: CWH); EOS Energy Enterprise, Inc. (NASDAQ: EOSE); and Soleno Therapeutics, Inc. (NASDAQ: SLNO): Grabar Law Office Investigates Claims on Your Behalf - GlobeNewswire Inc.
SLNO ALERT: Securities Class Action Lawsuit Against Soleno Therap - The National Law Review
Soleno Therapeutics Faces Class Action Lawsuit Deadline - National Today
FinancialContentSLNO ALERT: Securities Class Action Lawsuit Against Soleno Therapeutics, Inc. (SLNO)Contact Kaplan Fox Before Deadline on May 5, 2026 - FinancialContent
Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action LawsuitContact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - PR Newswire
INVESTOR ALERT: Securities Class Action Filed Against Soleno Therapeutics, Inc. – Investors Encouraged to Contact Kirby McInerney LLP - The AI Journal
SLNO CLASS ACTION DEADLINE: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Soleno Therapeutics, Inc. (NASDAQ: SLNO) and Lead Plaintiff Deadline on May 5, 2026 - NewMediaWire
Notice to Long-Term Investors of Soleno Therapeutics, Inc. (SLNO): Grabar Law Office Investigates Claims on Your Behalf - TMX Newsfile
Soleno Therapeutics (SLNO) slides 8.1% as litigation headlines resurface around prior short-seller claims - Quiver Quantitative
ROSEN, A TOP RANKED LAW FIRM, Encourages Soleno Therapeutics, Inc. Investors to Secure Counsel ... - Bluefield Daily Telegraph
Soleno Therapeutics Investors Urged to Join Securities Fraud Lawsuit - National Today
SLNO Investors Urged to Join Soleno Therapeutics Securities Fraud Lawsuit - National Today
DEADLINE ALERT for BSX, EOSE, SLNO, and NKTR: The Law - GlobeNewswire
Soleno Therapeutics, Inc. (SLNO) Class Action Lawsuit: Investors Face May 5, 2026, Deadline - GlobeNewswire
SLNO Shareholder Alert: May 5, 2026 Lead Plaintiff Deadline - GlobeNewswire
SLNO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Soleno Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
2026-03-13 | SLNO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Soleno Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:SLNO | Press Release - Stockhouse
Soleno Therapeutics, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsSLNO - lelezard.com
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Sahm
Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hyperphagia Drug Launch Disruptions -- Hagens Berman - lelezard.com
Soleno Therapeutics, Inc. (SLNO) Investors: May 5, 2026, Deadline in Securities Fraud Class Action Lawsuit – Contact Kessler Topaz Meltzer & Check, LLP - The AI Journal
Soleno Therapeutics Investors Encouraged to Contact Kaplan Fox Before Deadline - National Today
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Soleno Therapeutics, Inc. (SLNO) - ACCESS Newswire
SOLENO THERAPEUTICS DEADLINE: Investors of Soleno Therapeutics, I - The National Law Review
Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages Soleno Therapeutics, Inc. (SLNO) Shareholders To Inquire About Securities Fraud Class Action - The AI Journal
SOLENO THERAPEUTICS DEADLINE: Investors of Soleno Therapeutics, Inc. (SLNO) are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on May 5, 2026 - The Globe and Mail
SLNO Lawsuit Alleges Allegedly Conducting Sham Clinical TrialsSoleno Therapeutics, Inc. Investors Face Losses Following Allegedly Conducting Sham Clinical Trials: SueWallSt - Stock Titan
SOLENO THERAPEUTICS, INC. (SLNO) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Soleno ... - Bluefield Daily Telegraph
SOLENO THERAPEUTICS, INC. (SLNO) SHAREHOLDER ALERT - GlobeNewswire
SLNO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Soleno Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Soleno Therapeutics Shareholder Alert: ClaimsFiler Reminds - GlobeNewswire
Soleno Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of ... - Caledonian Record
Soleno Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Soleno Therapeutics, Inc. - GlobeNewswire Inc.
Soleno Therapeutics, Inc. Class Action Notice: Robbins LLP Reminds Investors of the Lead ... - Caledonian Record
Soleno Therapeutics, Inc. Class Action Notice: Robbins LLP - GlobeNewswire
INVESTOR NOTICE: Soleno Therapeutics Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – RGRD Law - marketscreener.com
Law Offices of Howard G. Smith Encourages Soleno Therapeutics, Inc. (SLNO) Shareholders To Inquire About Securities Fraud Class Action - WFMZ.com
Law Offices of Frank R. Cruz Encourages Soleno Therapeutics, Inc. (SLNO) Shareholders To Inquire About Securities Fraud Class Action - The AI Journal
SLNO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Soleno Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
SLNO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026 – Company AnnouncementFT.com - Financial Times
SLNO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026 - Sahm
Soleno Therapeutics, Inc. Notice of May 5, 2026 Application - GlobeNewswire
Kaplan Fox Alerts Investors to a Securities Class Action Against Soleno Therapeutics, Inc. (SLNO)Deadline is May 5, 2026 - NewMediaWire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Soleno - GlobeNewswire
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
SOLENO THERAPEUTICS, INC. (SLNO) INVESTOR ALERT Investors With Large Losses in Soleno ... - Bluefield Daily Telegraph
SOLENO THERAPEUTICS, INC. (SLNO) INVESTOR ALERT Investors - GlobeNewswire
Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hyperphagia Drug Launch DisruptionsHagens Berman - The Malaysian Reserve
Soleno Therapeutics Inc Azioni (SLNO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):